CANNAPHARMARX, INC. Balance Sheet
CPMD|11 years of annual SEC 10-K data (FY2014-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
CANNAPHARMARX, INC. had $7M in total assets with negative shareholders' equity of $30M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.8K | $2.2K | $2.3K | $27.8K | $335.0K | $1.5K | $464.1K | $0 | $0 | $2.6K | $1.6M |
| Accounts Receivable | $164.4K | $1.7K | - | - | - | - | - | - | - | - | - |
| Inventory | $1.1M | $996.3K | - | - | - | - | - | - | - | - | - |
| Current Assets | $1.3M | $1.0M | $100.0K | $29.5K | $467.6K | $1.9M | $598.8K | $0 | $1.7K | $12.1K | $1.6M |
| PP&E (Net) | $127.0K | $137.2K | $107.8K | $6.0K | $1.6M | $1.5M | $1.7M | $0 | $0 | $0 | $97.7K |
| Goodwill | - | - | - | - | $0 | $6.4M | $6.1M | - | - | - | - |
| Total Assets | $7.0M | $10.8M | $5.4M | $114.3K | $8.7M | $16.0M | $10.1M | $0 | $1.7K | $12.1K | $1.8M |
| Current Liabilities | $31.6M | $25.8M | $17.2M | $13.0M | $17.5M | $5.7M | $3.8M | $964.3K | $959.3K | $696.6K | $1.9M |
| Shareholders' Equity | -$30.2M | -$19.8M | $17.3M | -$12.9M | -$8.8M | $4.9M | -$286.3K | -$964.3K | -$957.7K | -$684.5K | -$288.2K |